-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pc9TWn59s6otvpQwx76cb5dU0tonV/xwWJAwcYISY4lCRJveicr2Ugbxe8cn2McB xCL6sBD4iVly51wqp8drXA== 0000950117-98-000292.txt : 19980218 0000950117-98-000292.hdr.sgml : 19980218 ACCESSION NUMBER: 0000950117-98-000292 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19980217 SROS: AMEX GROUP MEMBERS: CHASE MANHATTAN CORP /DE/ GROUP MEMBERS: ISRAEL DISCOUNT BANK OF NEW YORK GROUP MEMBERS: THE BANK OF NEW YORK SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HALSEY DRUG CO INC/NEW CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-38110 FILM NUMBER: 98542570 BUSINESS ADDRESS: STREET 1: 1827 PACIFIC ST CITY: BROOKLYN STATE: NY ZIP: 11233 BUSINESS PHONE: 7184677500 MAIL ADDRESS: STREET 2: 1827 PACIFIC ST CITY: BROOKLYN STATE: NY ZIP: 11233 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CHASE MANHATTAN CORP /DE/ CENTRAL INDEX KEY: 0000019617 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 132624428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 270 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122706000 MAIL ADDRESS: STREET 1: 270 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: CHEMICAL BANKING CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CHEMICAL NEW YORK CORP DATE OF NAME CHANGE: 19880508 SC 13G/A 1 THE CHASE MANHATTAN CORPORATION ET AL SC13G, AM #1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 -------------------- SCHEDULE 13G Information Pursuant to Rules 13d-1 and 13d-2 Under the Securities Act of 1934 (Amendment No. 1) Halsey Drug Co., Inc. ---------------------------------------- (Name of Issuer) Common Stock ---------------------------------------- (Title of Class of Securities) 406369 ---------------------------------------- (CUSIP Number) ---------------------------------------- The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. - --------------------------- --------------------- CUSIP No. 406369 13G Page 2 of 11 Pages - --------------------------- --------------------- - ---------------------------------------------------------------------------------------------- 1 Name of Reporting Person The Chase Manhattan Corporation I.R.S. Identification No. of Above Person - ---------------------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] - ---------------------------------------------------------------------------------------------- 3 SEC Use Only - ---------------------------------------------------------------------------------------------- 4 Citizenship or Place of Organization Delaware - ---------------------------------------------------------------------------------------------- Number of 5 Sole Voting Power Shares ---------------------------------------------------------------------------- Beneficially 6 Shared Voting Power Owned by ---------------------------------------------------------------------------- Each 7 Sole Dispositive Power Reporting ---------------------------------------------------------------------------- Person With 8 Shared Dispositive Power - ---------------------------------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by Each Reporting Person - ---------------------------------------------------------------------------------------------- 10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] - ---------------------------------------------------------------------------------------------- 11 Percent of Class Represented by Amount in Row (9) - ---------------------------------------------------------------------------------------------- 12 Type of Reporting Person (See Instructions) HC - ----------------------------------------------------------------------------------------------
- --------------------------- --------------------- CUSIP No. 406369 13G Page 3 of 11 Pages - --------------------------- --------------------- - ---------------------------------------------------------------------------------------------- 1 Name of Reporting Person The Bank of New York I.R.S. Identification No. of Above Person - ---------------------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] - ---------------------------------------------------------------------------------------------- 3 SEC Use Only - ---------------------------------------------------------------------------------------------- 4 Citizenship or Place of Organization New York - ---------------------------------------------------------------------------------------------- Number of 5 Sole Voting Power Shares ---------------------------------------------------------------------------- Beneficially 6 Shared Voting Power Owned by ---------------------------------------------------------------------------- Each 7 Sole Dispositive Power Reporting ---------------------------------------------------------------------------- Person With 8 Shared Dispositive Power - ---------------------------------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by Each Reporting Person - ---------------------------------------------------------------------------------------------- 10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] - ---------------------------------------------------------------------------------------------- 11 Percent of Class Represented by Amount in Row (9) - ---------------------------------------------------------------------------------------------- 12 Type of Reporting Person (See Instructions) BK - ----------------------------------------------------------------------------------------------
- --------------------------- --------------------- CUSIP No. 406369 13G Page 4 of 11 Pages - --------------------------- --------------------- - ---------------------------------------------------------------------------------------------- 1 Name of Reporting Person Israel Discount Bank of New York I.R.S. Identification No. of Above Person - ---------------------------------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] - ---------------------------------------------------------------------------------------------- 3 SEC Use Only - ---------------------------------------------------------------------------------------------- 4 Citizenship or Place of Organization New York - ---------------------------------------------------------------------------------------------- Number of 5 Sole Voting Power Shares ---------------------------------------------------------------------------- Beneficially 6 Shared Voting Power Owned by ---------------------------------------------------------------------------- Each 7 Sole Dispositive Power Reporting ---------------------------------------------------------------------------- Person With 8 Shared Dispositive Power - ---------------------------------------------------------------------------------------------- 9 Aggregate Amount Beneficially Owned by Each Reporting Person - ---------------------------------------------------------------------------------------------- 10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] - ---------------------------------------------------------------------------------------------- 11 Percent of Class Represented by Amount in Row (9) - ---------------------------------------------------------------------------------------------- 12 Type of Reporting Person (See Instructions) BK - ----------------------------------------------------------------------------------------------
- --------------------------- --------------------- CUSIP No. 406369 13G Page 5 of 11 Pages - --------------------------- --------------------- This Amendment No. 1 amends and supplements the Statement on Schedule 13G (the "Schedule 13G"), originally filed in 1995 with the Securities and Exchange Commission. Items 1-10 of the Schedule 13G are hereby amended in their entirety to read as follows: Item 1(a) Name of Issuer: Halsey Drug Co., Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 1827 Pacific Street, Brooklyn, New York 11233 Item 2(a) Name of Person(s) Filing: The Chase Manhattan Corporation Name of Person(s) Filing: The Chase Manhattan Bank as successor in interest to The Chase Manhattan Bank, N.A. Name of Person(s) Filing: The Bank of New York Name of Person(s) Filing: Israel Discount Bank of New York Item 2(b) Address of Principal Business Office: 270 Park Avenue, New York, New York 10017 Address of Principal Business Office: 270 Park Avenue, New York, New York 10017 Address of Principal Business Office: One Wall Street, New York, New York 10286 - --------------------------- --------------------- CUSIP No. 406369 13G Page 6 of 11 Pages - --------------------------- --------------------- Address of Principal Business Office: 511 Fifth Avenue, New York, New York 10017 Item 2(c) Citizenship: Delaware (The Chase Manhattan Corporation) Citizenship: New York (The Chase Manhattan Bank) Citizenship: New York (The Bank of New York) Citizenship: New York (Israel Discount Bank of New York) Item 2(d) Title of Class of Securities: Common Stock of Halsey Drug Co., Inc. (warrants to purchase) Item 2(e) CUSIP Number: 406369 Item 3 If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act, (b) [X] Bank as defined in Section 3(a)(6) of the Act, (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act, (d) [ ] Investment Company registered under Section 8 of the Investment Company Act, (e) [ ] Investment Advisor registered under Section 203 of the Investment Advisors Act of 1940, - --------------------------- --------------------- CUSIP No. 406369 13G Page 7 of 11 Pages - --------------------------- --------------------- (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see 13d-1(b)(1)(ii)(F), (g) [X] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G); see Item 7, (h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H). Item 4 Ownership. [Not applicable.] Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof, the reporting persons have ceased (collectively) to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More than 5% on Behalf of Another Person. [Not Applicable] Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. As to the Chase Manhattan Corporation, this schedule is filed pursuant to Rule 13d-1(b)(ii)(G). The Chase Manhattan Bank is a wholly-owned subsidiary of The Chase Manhattan Corporation and is a bank as defined in Section 3(a)(6) of the Act. Item 8. Identification and Classification of Members of the Group. The Chase Manhattan Corporation ("CMC") is a parent holding company and each of The Chase Manhattan Bank, as successor in interest to The Chase Manhattan Bank, N.A. ("Chase"), The Bank of New York ("BNY") and Israel Discount Bank of New York ("IDB") is a bank as defined in Section 3(a)(6) of the Act. CMC, Chase, BNY and IDB expressly disclaim that they constitute a "group" for purposes of Section 13(d) of the Act and the Rules and Regulations promulgated thereunder. Chase, BNY and IDB are parties to a Credit Agreement, dated as of December 22, 1992, among Halsey Drug Co., Inc. (the - --------------------------- --------------------- CUSIP No. 406369 13G Page 8 of 11 Pages - --------------------------- --------------------- "Issuer"), Chase, BNY and IDB (such agreement, as amended from time to time, the "Credit Agreement"). In connection with various amendments to the Credit Agreement, Chase, BNY and IDB have received warrants to purchase common stock of the Issuer. Such warrants, which were received in 1994 or early 1995 (but were all dated 1994), are the basis for this filing. Item 9. Notice of Dissolution of the Group. [Not Applicable] Item 10. Certification. By signing below each of the undersigned certifies that, to the best of such person's knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. - --------------------------- --------------------- CUSIP No. 406369 13G Page 9 of 11 Pages - --------------------------- --------------------- SIGNATURE After reasonable inquiry and to the best of their knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct. Date: February 17, 1998 THE CHASE MANHATTAN CORPORATION By: /s/ ANTHONY J. HORAN _________________________________ Name: Anthony J. Horan Title: Corporate Secretary Date: February 17, 1998 THE CHASE MANHATTAN BANK By: /s/ DOUGLAS A. JENKS _________________________________ Name: Douglas A. Jenks Title: Vice President Dated: February 17, 1998 THE BANK OF NEW YORK By: /s/ J.B. LIFTON _________________________________ Name: J.B. Lifton Title: Vice President Dated: February 17, 1998 ISRAEL DISCOUNT BANK OF NEW YORK By: /s/ HOWARD WEINBERG _________________________________ Name: Howard Weinberg Title: First Vice President By: /s/ R. DAVID KORNGRUEN _________________________________ Name: R. David Korngruen Title: Vice President Exhibit Index Exhibit I Joint Filing Agreement, dated as of October 23, 1995, by and among The Chase Manhattan Bank, The Bank of New York and Israel Discount Bank. EX-99 2 EXHIBIT I JOINT FILING AGREEMENT In accordance with Rule 13d-1(f) of the Securities Exchange Act of 1934, as amended, (the "Act") the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to common stock of Halsey Drug Co., Inc. (including warrants to acquire the same) and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. Notwithstanding this Joint Filing Agreement, the persons named below disclaim that they constitute a "group" for purposes of Section 13d of the Act and the rules and regulations promulgated in connection therewith. In evidence thereof, the undersigned have executed this Joint Filing Agreement as of the 23rd day of October 1997. THE CHASE MANHATTAN CORPORATION 10/24/95 _________________________________________ (Date) JOHN V. CAULFIELD _________________________________________ (Signature) John V. Caulfield V.P. _________________________________________ (Name/Title) THE CHASE MANHATTAN BANK 10/24/95 _________________________________________ (Date) JOHN V. CAULFIELD _________________________________________ (Signature) John V. Caulfield V.P. _________________________________________ (Name/Title) THE BANK OF NEW YORK 10/23/95 _________________________________________ (Date) RICHARD MAYBAUM _________________________________________ (Signature) Richard Maybaum A.V.P. _________________________________________ (Name/Title) ISRAEL DISCOUNT BANK OF NEW YORK October 23, 1995 _________________________________________ (Date) GEORGE S. DALLAL _________________________________________ (Signature) George S. Dallal, V.P. _________________________________________ (Name/Title) October 23,1995 _________________________________________ (Date) R. DAVID KORNGRUEN _________________________________________ (Signature) R. David Korngruen A.V.P. _________________________________________ (Name/Title) -----END PRIVACY-ENHANCED MESSAGE-----